Two Domains within the Adenovirus Type 12 E1A UniqueSpacerHave Disparate Effects on the Interaction of E1A with P105-Rb and the Transformation of Primary Mouse Cells-Reference-Cited by-同舟云学术

Two Domains within the Adenovirus Type 12 E1A UniqueSpacerHave Disparate Effects on the Interaction of E1A with P105-Rb and the Transformation of Primary Mouse Cells

Published:1999-04 Issue:1 Volume:257 Page:45-53
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Rumpf Heike,Esche Helmut,Kirch Hans-Christoph

Publisher

Elsevier BV

Subject

Virology

Reference48 articles.

1. Adenovirus E1A proteins can dissociate heteromeric cellular complexes involving the E2F transcription factor;Bagchi;Cell,1990

2. Functional interactions within adenovirus E1A complexes;Barbeau;Oncogene,1994

3. Pre-early adenovirus 5 gene product regulates synthesis of early messenger RNAs;Berk;Cell,1979

4. The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation;Bondesson;EMBO J.,1992

5. Regulation of viral and cellular gene expression by E1A proteins encoded by the oncogenic adenovirus type 12;Brockmann;Curr. Topics Microbiol. Immunol.,1995

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of alterations of Rb2/p130 tumor suppressor in all-trans-retinoic acid resistant SK-OV3 ovarian carcinoma cells;Journal of Cellular Physiology;2008-10

2. Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid;Oncogene;2006-08

3. E1A-Based Determinants of Oncogenicity in Human Adenovirus Groups A and C;Current Topics in Microbiology and Immunology;2004

4. Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system;Oncogene;2002-11

5. Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells;Cancer Gene Therapy;2000-07